Recently, there's been a surge in activity from various institutional investors in The Clorox Company (CLX). Entities such as Advisors Preferred LLC, Y Intercept Hong Kong Ltd, J.W. Cole Advisors Inc., and Wakefield Asset Management LLLP, among others, have increased their investment or initiated new positions in CLX. However, some entities like Victory Capital Management and Beaton Management Co. have reduced their stake. While JPMorgan has trimmed CLX's price target, its Neutral rating remains. Major investments, like that of New York State Common Retirement Fund and Slow Capital Inc., show strong confidence in CLX's capacity for value creation.
Notably, CLX's Q3 2025 earnings showcased resilient margins despite challenging market conditions. While Clorox was recently involved in a lawsuit against Cognizant due to a 2023 cyberattack, it has plans to announce its fourth-quarter and fiscal year 2025 results, backed by an innovation strategy for elevating everyday essentials. Retirements like Kevin Jacobsen's as CFO (new CFO being Luc Bellet), coupled with Gina Boswell's election to CLX's Board of Directors, indicate a changing landscape within the company's leadership structure.
Clorox Company CLX News Analytics from Mon, 23 Sep 2024 07:00:00 GMT to Sun, 27 Jul 2025 01:28:48 GMT - Rating 3 - Innovation 5 - Information 7 - Rumor -5
